Experiments

Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).

• Exploring the mechanism of action of abemaciclib in breast cancer through circulating chromatin fragments.

  PMID 41845059 · PMC13149665 · Communications medicine · 2026 · 8 claims · 5 setups

  Full-text index only

  cfDNA concentrations are significantly higher in breast cancer patients than healthy donors and decline following abemaciclib therapy

  serum t47d edger-normalized cfdna proliferation pathway

• Environmental selection overturns the decay relationship of soil prokaryotic community over geographic distance across grassland biotas.

  PMID 35073255 · PMC8828049 · eLife · 2022 · 8 claims · 7 setups

  Has reproduction · 57

  Prokaryotic community similarity follows a significant U-shape relationship over geographic distance up to 4000 km, decreasing within biotas but increasing across biotas after a tipping point of 1760-1920 km

  soil grassland 16s plant soil

• The complement system contributes to the immunosuppressive microenvironment of uveal melanoma.

  PMID 41803879 · PMC13130498 · Journal of translational medicine · 2026 · 8 claims · 8 setups

  Full-text index only

  Primary UM (pUM) preferentially expresses early complement pathway components over terminal membrane attack complex elements, with early factors showing prognostic significance.

  short-term metastatic normal pum bulk label-free single-cell

• Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.

  PMID 41484081 · PMC12858953 · Nature communications · 2026 · 8 claims · 8 setups

  Full-text index only

  Combined low-dose CTX + anti-CSF-1R (SNDX-ms6352) is highly effective against aggressive metastatic Trp53-null TNBC models with high macrophage infiltration, producing complete tumor regression in claudin-low models.

  trp53-null complete t12 cell-deficient imaging survival tumor

• ROR1-PI3K/AKT signaling drives adaptive resistance to cell cycle blockade in TP53 mutated ovarian cancer.

  PMID 41748546 · PMC13004963 · Cell death & disease · 2026 · 7 claims · 8 setups

  Full-text index only

  A shared PI3K/AKT-regulated signaling node governs drug adaptation across all long-term resistant (lt-res) ADA and PTX models

  hgsoc kuramochi jhos2 parental long-term inducible overexpression